However, another group has reported that tamoxifen induces sustained activation of ERK in tumor cells leading to rapid cell death indicating an involvement of ERK signaling in the tamoxifen response of ERα-positive cancer cells [11]. The gene discussed is MAPK1; the disease is cancer.